International News

Drug to reduce bleeding could treat COVID-19
International News

Drug to reduce bleeding could treat COVID-19

A recent study has shown that aprotinin, a drug that reduces the risk of bleeding during surgery, can stop the novel coronavirus from entering host cells. The drug could serve to prevent severe cases of COVID-19, the authors say. With a number of vaccines on the way, there is now light at the end of the tunnel…

Robot reminds shoppers to wear masks
International News

Robot reminds shoppers to wear masks

Japan: A shop in Japan has enlisted a robot to ensure customers are wearing masks, as the country prepares for a possible third wave of coronavirus infections. Robovie, developed by the Advanced Telecommunications Research Institute International in Kyoto, is able to pick out customers who aren’t wearing masks and politely ask them to cover up. It can also intervene when…

WHO records 65 virus cases, with one cluster, at HQ
International News

WHO records 65 virus cases, with one cluster, at HQ

GENEVA: The World Health Organisation (WHO) has recently recorded 65 cases of the coronavirus among staff based at its headquarters, including at least one cluster of infections, an internal email obtained by this news agency shows, despite the agency’s past assertions that there has been no transmission at the Geneva site. The revelation comes amid…

Denmark will kill all mink, citing coronavirus infections
International News

Denmark will kill all mink, citing coronavirus infections

Denmark: Government officials recently said that a mutation in the virus could interfere with vaccine effectiveness in humans. The Danish government will slaughter millions of mink at more than 1,000 farms, citing concerns that a mutation in the novel coronavirus that has infected the mink could possibly interfere with the effectiveness of a vaccine for…

Remdesivir provides little effect on COVID-19: WHO
International News, Research

Remdesivir provides little effect on COVID-19: WHO

New York: Remdesivir, an antiviral drug initially developed to treat Ebola by the pharmaceutical company Gilead, has “little or no effect” on survival for people in hospital with COVID-19, a World Health Organization (WHO) trial has found. As part of its SOLIDARITY trial, WHO researchers tested the effects of four potential treatments, including antiviral drugs remdesivir and interferon-β1a, the…

1 2 3 4 28

Medical News is the only periodical in Pakistan which has 3 simultaneous editions from Karachi, Islamabad and online.

Latest E-Paper
Like Us On Facebook
For Subscription